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Abstract 31 
The impact of Montmorency tart cherry concentrate [MC] on physiological indices and functional 32 
performance was examined following a bout of high intensity stochastic cycling.  Trained cyclists (n = 33 
16) were equally divided into 2 groups (MC or isoenergetic placebo [PLA]) and consumed 30 mL of 34 
supplement, twice per day for eight consecutive days. On the fifth day of supplementation, 35 
participants completed a 109 minute cycling trial designed to replicate road race demands.  36 
Functional performance (maximum voluntary isometric contraction [MVIC], cycling efficiency, 6-37 
second peak cycling power) and delayed onset muscle soreness [DOMS] were assessed at baseline, 38 
24, 48 and 72 h post-trial.  Blood samples collected at baseline, immediately pre and post-trial, and 39 
1, 3, 5, 24, 48 and 72 h post-trial were analysed for indices of inflammation (IL-1-β, IL-6, IL-8, TNF-α, 40 
hsCRP), oxidative stress (lipid hydroperoxides) and muscle damage (creatine kinase).  MVIC (P < 0.05) 41 
did not decline in the MC group (vs. PLA) across the 72 h post trial period and economy (P < 0.05) 42 
was improved in the MC group at 24 h.   IL-6 (P < 0.001) and hsCRP (P < 0.05) responses to the trial 43 
were attenuated with MC (vs. PLA).  No other blood markers were significantly different between 44 
MC and PLA groups.  The results of the study suggest that Montmorency cherry concentrate can be 45 
an efficacious functional food for accelerating recovery and reducing exercise-induced inflammation 46 
following strenuous cycling exercise.  47 
 48 
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Introduction 51 
Athletic training and competition causes physiological stress that is followed by a period of recovery 52 
(Leeder et al. 2012).  A high-priority for athletes is the ability to accelerate recovery in order to allow 53 
subsequent training or competition to be attained at the requisite intensity and as such, numerous 54 
recovery interventions have been investigated (Barnett 2006; Howatson et al. 2008).  Recently, 55 
antioxidant supplementation has received a great deal of attention (Urso et al. 2003; Powers et al. 56 
2008; Howatson et al. 2010; McAnulty et al. 2011) due to the purported ability to reduce 57 
inflammation (Bell et al. 2013; Kelley et al. 2013) and oxidative stress (Mastaloudis et al. 2006; 58 
Goldfarb et al. 2011; Peternelj et al. 2011; Bell et al. 2013) that manifest during and following 59 
intense exercise.  Optimum recovery is of great importance to athletes in numerous sporting 60 
scenarios where repeated days performance might be required (Bell et al. 2013).  Consequently, 61 
antioxidant supplements may have a role to play in optimising recovery following strenuous 62 
exercise. 63 
 64 
Montmorency tart cherries have been proposed as a recovery supplement due to their high 65 
concentrations of phytochemicals, and in particular, the flavanoids anthocyanins (Howatson et al. 66 
2010; McCune et al. 2011; Bell et al. 2013).  Anthocyanins have been shown to reduce oxidative 67 
stress and inhibit the activity of the inflammatory mediator cyclooxygenase (COX) to a similar extent 68 
as non-steroidal anti-inflammatory drugs (NSAIDs) (Wang et al. 1999; Seeram et al. 2001).   These 69 
findings have led to a series of studies investigating the use of Montmorency cherries influencing 70 
recovery (Connolly et al. 2006; Ducharme et al. 2009; Howatson et al. 2010; Kuehl et al. 2010; 71 
Bowtell et al. 2011; Bell et al. 2014).  Connolly et al (2006) was the first to demonstrate accelerated 72 
muscle function recovery with Montmorency cherry supplementation in the days following 73 
damaging high intensity eccentric exercise, (Connolly et al. 2006).  Using a similar study design, 74 
Bowtell et al (2011) also found that following eccentric-induced muscle damaging exercise, knee 75 
extensor force recovered more rapidly with Montmorency cherries compared to an isoenergetic 76 
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placebo (Bowtell et al. 2011).  Unfortunately, Connolly et al (2006) did not measure markers of 77 
inflammation or oxidative stress and although Bowtell et al (2011) reported that a trend towards 78 
lower protein oxidation (protein carbonyls) with Montmorency cherry supplementation, there were 79 
no differences in indices of inflammation. 80 
 81 
An attenuated inflammatory and oxidative stress response to exercise and more rapid recovery of 82 
muscle performance has also been reported using a different model of exercise when supplementing 83 
with Montmorency cherries (Howatson et al. 2010).  Howatson et al (2010) showed that following 84 
marathon running, where there is high mechanical and metabolic stress, inflammation (interleukin-6 85 
[IL-6], high-sensitivity C-reactive protein [hsCRP]) and oxidative stress (thiobarbituric acid reactive 86 
substances [TBARS]) were lower in the cherry supplemented group versus a placebo.  Additionally, in 87 
the 48 h post-race, recovery of maximal force during a voluntary isometric contraction (MVIC) of the 88 
knee extensors was improved in the Montmorency cherry group compared to the placebo group.  In 89 
contrast to Bowtell et al. (2011), the marathon running used in this study induced systemic 90 
inflammation sufficiently to demonstrate changes in the inflammatory response between groups.  91 
Both studies, however, reported reduced oxidative stress responses to the exercise protocol; 92 
Howatson et al (2010) reported attenuated lipid peroxidation, whilst Bowtell et al. (2011) reported 93 
reduced protein oxidation.  These discrepancies might be explained by the differences in exercise 94 
mode used to induce the stress response.  Bowtell et al (2011) used a protocol designed exclusively 95 
to induce a mechanical stress with high force eccentric muscle actions.  Conversely, the marathon 96 
running used by Howatson et al (2010), placed a high degree of both mechanical and metabolic 97 
stress due to the eccentric muscle actions and prolonged high energy expenditure involved in long 98 
distance running (Howatson et al. 2010).  Collectively,, it is conceivable that Montmorency cherries 99 
could also be suited to aiding recovery by reducing inflammation associated with exercise involving a 100 
high metabolic component.   101 
 102 
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Consequently, exercise posing a challenge that is predominantly metabolic in nature, provides a 103 
highly appropriate model to investigate the impact of Montmorency cherries on recovery and may 104 
provide insight into the relationship between inflammation, oxidative stress and muscle 105 
performance.  Cycling is a sport that requires little or no eccentric muscle actions, but requires 106 
prolonged high metabolic activity, that can cause perturbations in inflammation, oxidative stress and 107 
muscle function (Bell et al. 2014).  Additionally, given the evidence from previous research regarding 108 
improved strength recovery with Montmorency cherries (Connolly et al. 2006; Howatson et al. 2010; 109 
Bowtell et al. 2011), the assessment of muscle function following an exclusively metabolic challenge, 110 
such as cycling, may translate to other exercise paradigms where a metabolic (as opposed to 111 
mechanical) physiological stress is imposed.  112 
 113 
In this study, the primary objective was to identify the impact of Montmorency cherry 114 
supplementation on recovery of muscle function following an exercise stress induced through a 115 
metabolic challenge (high-intensity stochastic cycling). It was hypothesised that supplementation 116 
with Montmorency cherries would accelerate recovery of muscle function and this would be 117 
accompanied by attenuation in the exercise-induced inflammation and oxidative stress responses 118 
following simulated road race cycling.     119 
 120 
Materials and Methods 121 
Participants 122 
Sixteen healthy, male trained cyclists (mean ± SD age, height, mass, VO2peak was 30 ± 8 yrs; 181.1 ± 123 
6.7 cm, 76.5 ± 9.2 kg, 61.6 ± 10.4 mL.kg-1.min-1, respectively) were recruited to take part in the study.  124 
Training and health status were assessed through the completion of a cycling training history and 125 
health screening questionnaire, respectively.  For inclusion, participants must have cycle trained for 126 
>5 hours per week over the preceding 24 months.  Additionally, participants agreed to withdraw 127 
from any other exercise throughout the duration of this study.  Exclusion criteria for the study 128 
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included; >45 years of age, female, allergy to specific fruit products, currently taking any nutritional 129 
supplements or medication, history of gastrointestinal, renal or cardiovascular disease.  Following 130 
institutional ethical clearance, written, informed consent was collected from all participants after 131 
both verbal and written briefings on the requirements of the study. 132 
 133 
Study Design 134 
The study utilised a double blind, counterbalanced, placebo controlled independent groups design in 135 
order to identify the effects of Montmorency tart cherry concentrate (MC) on recovery from a 136 
metabolic challenge (prolonged, high-intensity, stochastic cycling).  The protocol required 137 
participants to complete 6 visits to the laboratory across a period of up to 20 days (Figure 1).  Briefly, 138 
on visit 1, participants completed preliminary aerobic profiling (�̇O2peak, Wmax) and baseline measures 139 
of functional performance (lower limb active muscles soreness assessment [DOMS], cycling economy 140 
[CE], 6-second peak cycling power and maximum isometric voluntary contraction of the quadriceps 141 
[MIVC]).  Participants returned to the laboratory within 2-4 days and completed familiarisation of 142 
the exercise protocol only.  Following this, participants were subject to stratified randomisation 143 
based on VO2peak and then allocated to either MC or Placebo (PLA) groups (63.1 ± 11.0 vs. 60.2 ± 10.2 144 
mL.kg.min-1, respectively).  Participants completed a 4 day supplement loading phase leading to visit 145 
3, which began a minimum of 7 days following the familiarisation trial.  Visit 3 consisted of a 146 
prolonged, high-intensity, stochastic cycling trial lasting 109 minutes (Figure 2) performed on an 147 
electromagnetically braked, cycle ergometer (Velotron RacerMate, Seattle, WA).  Visits 4-6 took 148 
place 24, 48 and 72 h post-trial, during which participants repeated the baseline measures, 149 
additionally, each visit was conducted at 7.45am following an overnight fast to avoid diurnal 150 
variation and ensure consistent intervals between supplementation and exercise.  Venous blood 151 
samples were collected at baseline (prior to 4 the day loading phase), immediately pre-trial, 152 
immediately post-trial and 1, 3, 5, 24, 48 and 72 h post-trial for markers of inflammation, oxidative 153 
stress and muscle damage.    154 
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Supplementation and dietary control 155 
Following group allocation, participants were provided with MC or placebo (PLA) supplementation 156 
and instructed to consume 30 mL of the supplement twice per day (8 am and 6 pm) for 8 157 
consecutive days (4 days pre-, on the day of, and 3 days post trial).  On the visits involving exercise 158 
(visits 3-6) supplementation was consumed 15 minutes following venous blood sampling and 10 159 
minutes prior to performance.  Previous research (Bitsch et al. 2004; Kurilich et al. 2005) has 160 
demonstrated that systemic anthocyanin bioavailability increases to a peak between 1-2 hours post-161 
ingestion, which coincides with the completion of the exercise tasks in this study.  The concentrate 162 
was consumed with 100 mL of water and this supplementation strategy has previously been used in 163 
previous work demonstrating accelerated recovery (Bowtell et al. 2011; Bell et al. 2014).  According 164 
to ŵaŶufaĐturer͛s speĐifiĐatioŶ ;CherrǇ AĐtiǀe Ltd, HaŶǁorth, UKͿ, eaĐh ϯϬ ŵL dose of MC ĐoŶtaiŶed 165 
~90-110 Montmorency tart cherries; independent laboratory analysis shows the juice to provide 9.2 166 
mg.mL-1 of anthocyanins and  669.4 mg.mL-1 of carbohydrate (Atlas Biosciences, Tuscon, AZ).  The 167 
PLA was a commercially available mixed berry cordial (less than 5% fruit in concentrate form), mixed 168 
with 100 mL water and maltodextrin (MyProtein Ltd, Northwich, UK) until matched for carbohydrate 169 
content of the MC (20.07 g).  All supplements were prepared in opaque bottles by an independent 170 
member of the department in order to maintain the double blind design of the study. 171 
 172 
During the dosing period (4 days pre-trial to 3 days post trial), participants were required to adhere 173 
to a low-polyphenolic diet.  More specifically, fruits, vegetables, tea, coffee, alcohol, chocolate, 174 
cereals, wholemeal bread and grains were prohibited and in order to assess for dietary compliance, 175 
food diaries were completed for the duration of study, which has been used successfully in previous 176 
work (Howatson et al. 2012). 177 
 178 
Pre-trial Assessments 179 
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During the first visit to the laboratory, participants completed two cycling tests; a submaximal 180 
exercise test and an incremental ramp exercise test to exhaustion to elucidate maximal aerobic 181 
power (Wmax)), VO2peak and gas exchange threshold (GET); both tests were completed using the 182 
aforementioned electro-magnetically braked cycle ergometer.  The submaximal test required 183 
participants to begin cycling at 100 W, which increased by 25 W every 4 minutes.  Heart rate and 184 
capillary blood samples were taken from the earlobe in the last 30 s of each stage and immediately 185 
analysed for blood lactate concentration using a Biosen C-Line analyser (EKF Diagnostics, Cardiff, 186 
UK).  Cycling was terminated when the lactate turn-point had been reached (Davis et al. 1983).  187 
Throughout the submaximal test, pulmonary gas exchange was continually monitored through an 188 
online system (Oxycon Pro, CareFusion, San Diego, CA).  Data were averaged over the final 30 s of 189 
each stage in order to analyse for relative �̇O2 cost.  Following the completion of the submaximal 190 
test, participants were given 10 minutes rest prior to completing the incremental ramp test.  The 191 
ramp test consisted of 3 minutes of cycling at 100 W, followed by an increase in work rate of 1 W 192 
every 3 seconds (20 W.min-1) until the participant reached volitional exhaustion or cadence dropped 193 
below 70 rpm.  Breath-by-breath pulmonary gas exchange data was collected throughout the ramp 194 
protocol and �̇O2peak was calculated as the highest 30-second average (Bailey et al. 2009a).  Using 195 
the regression equation calculated from the submaximal �̇O2 data, and the �̇O2peak, it was then 196 
possible to identify the power output achieved at �̇O2peak (Wmax).  GET was determined using either 197 
the first disproportionate increase in CO2 production (�̇CO2) from visual inspection of individual plots 198 
of �̇CO2 vs. �̇O2  or an increase in expired ventilation (�̇E/�̇O2 with no increase in  �̇E/�̇CO2) (Bailey 199 
et al. 2009a). Saddle, handlebar height and fore/aft position was recorded and replicated 200 
throughout all further cycling tests in the study for each participant.   201 
 202 
Pre-Trial Functional Performance Assessment 203 
Prior to entering into the supplementation and trial period, participants completed a battery of 204 
physical tests in order to gain baseline measures of performance capability.  The battery consisted of 205 
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active muscles soreness assessment (DOMS), cycling economy (CE), 6-second peak cycling power 206 
and maximum voluntary isometric contraction of the quadriceps (MVIC).  DOMS was assessed using 207 
a 0-ϮϬϬ ŵŵ ǀisual aŶalogue sĐale, ǁith the phrases ͚No paiŶ͛ at oŶe eŶd aŶd ͚PaiŶ/SoreŶess as ďad 208 
as it Đould ďe͛ at the other (Howatson et al. 2010).  Participants completed a squat to approximately 209 
a 90° knee flexion before standing and immediately marked upon the scale to indicate their level of 210 
soreness (Howatson et al. 2010).  The cycling economy test consisted of a 10 minute cycle at the 211 
power output corresponding to 90% of the GET (Bailey et al. 2009a).  Breath-by-breath pulmonary 212 
gas exchange was monitored throughout and �̇O2 data was averaged across the final 4 minutes of 213 
the test to give the relative O2 cost for that intensity.  Following the CE test, 6-second peak power 214 
was determined.  A 5 minute standardised warm-up, was followed by the completion of a series of 215 
6-second maximal sprints through a range of gears, the gear which elicited the highest power output 216 
was subsequently used for all further 6 second peak power tests   A minimum of 3 minutes between 217 
sprints was enforced to allow for recovery.  MIVC of the dominant knee extensors was determined 218 
using a strain gauge (MIE Medical Research Ltd., Leeds, UK).  Participants were seated on a platform 219 
and the strain gauge was attached to the dominant ankle at an internal joint angle of 80° (verified by 220 
a goniometer).  Three submaximal trials were completed at approximately 50%, 70% and 90% of 221 
partiĐipaŶts͛ perĐeiǀed ŵaǆiŵuŵ, folloǁed ďǇ three ŵaǆiŵal trials, eaĐh separated ďǇ ϭ ŵiŶ.  222 
Participants were given standardised verbal encouragement for the duration of each 3 second 223 
contraction and the peak force was recorded as the baseline measure of MIVC.  Previous work from 224 
our lab has demonstrated the technical error of measurement to be 26 Newtons or 3.7% for this 225 
measure of muscle function (Leeder 2013). 226 
 227 
Fatigue Inducing Protocol 228 
Participants completed a 10 minute, self-selected warm-up on the cycle ergometer, which included 3 229 
x 3 second sprints at perceived efforts of 70%, 80% and 90%, occurring at 7, 7.5 and 8 minutes, 230 
respectively.  The main exercise task (Figure 2) was designed to replicate the demands of a road 231 
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cycling race and has previously been used in other cycling studies (Vaile et al. 2008; Bell et al. 2014).  232 
The task consisted of 66 sprints lasting 5, 10 or 15 seconds with a work (W) to recovery (R) ratio of 233 
1:6, 1:3 or 1:1.  Sprints were divided into nine sets, with an active recovery (ACT) period lasting 5 234 
minutes between sets 1-2, 2-3, 4-5, 5-6, 7-8 and 8-9.  All R and ACT periods were completed at a 235 
power of 40-50% of Wmax.  An additional 9 minutes of sustained effort was incorporated through the 236 
completion of three time trials (TT) lasting 2 minutes, 2 minutes and 9 minutes, respectively.  237 
Participants were instructed to complete as much work as possible during all TT periods and 238 
received verbal encouragement throughout.  Power output was collected throughout all trials at a 239 
frequency of 3 Hz and subsequently transformed into work done (kJ).  Water was available for 240 
participants to drink ad libitum and strong verbal encouragement was provided by the same 241 
researcher throughout the duration of the trial.   242 
 243 
Blood Sampling 244 
Blood sampling was conducted using venepuncture and following collection, tubes were 245 
immediately centrifuged at 2400 x g, 4°C for 15 minutes before having the supernatant removed and 246 
stored in aliquots.  Aliquots were then immediately stored at -80°C and subsequently analysed for 247 
indices of inflammation, oxidative stress and muscle damage. 248 
 249 
Muscle Damage Indices 250 
Serum creatine kinase (CK) was analysed using kinetic UV test (Olympus Analyser, Olympus 251 
Diagnostica GmbH, Hamburg) using the method based upon the recommendations of the 252 
International Federation of Clinical Chemistry (IFCC).  Inter- and intra-assay coefficients of variation 253 
were both 1.5%.  254 
 255 
Inflammatory Indices 256 
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Plasma tumour necrosis factor alpha (TNF-αͿ, iŶterleukiŶ-1-beta (IL-ϭβͿ, iŶterleukiŶ-6 (IL-6) and 257 
interleukin-8 (IL-8) were analysed using a multiplex electrochemiluminescence assay (Sector Imager 258 
2400, Meso Scale Discovery, Rockville, MD).  Intra and inter plate coefficients of variation were; 4.64 259 
aŶd ϭϭ.ϱ% ;TNFαͿ, ϲ.ϴ% aŶd ϵ.ϱ% ;IL-1- β), 4.9% and 8.8% (IL-6), 3.41% and 8.5% (IL-8) and 260 
respectively.  Serum high sensitivity C-reactive protein (hsCRP) was analysed through an 261 
immunoturbidimetric assay (Roche Modular P, Roche Diagnostics Ltd, Burgess Hill, UK).  Respective 262 
inter and intra assay coefficients of variation were 0.7% and 4.7%.        263 
   264 
Oxidative Stress Indices 265 
Plasma aqueous phase lipid hydroperoxides (LOOH) were assessed using the ferrous oxidation of 266 
xylenol orange method (FOX 1), using a modification of the methods by Wolff (1994) and 267 
Nouroozzadeh et al. (1994).  Briefly, this ferrous iron/xylenol orange (FOX) assay quantifies the 268 
susceptibility to iron-induced lipid hydroperoxide formation in blood.  The presence of iron ions in 269 
the assay protocol might therefore, yield slightly higher lipid hydroperoxide values compared with 270 
other methods.  However, all samples were quantified in duplicate as a single batch analysis 271 
therefore any artifactual increase as a result of iron ion contamination would be consistent across all 272 
biological samples. Using a spectrophotometer (U-2001, Hitachi, England) absorbance was read at 273 
560 nm against a linear standard curve (range 0–5 mol.L−1).  Inter- and intra-assay coefficients of 274 
variation were <4% and <2%, respectively. 275 
 276 
Statistical Analysis 277 
All data analyses were conducted using IBM SPSS Statistics 20 for Windows (Surrey, UK) and are 278 
reported as mean ± standard deviation.  Differences between blood marker variables were analysed 279 
by using a condition (MC v PLA) by time-point (Pre-supplement, Pre-trial, 1, 3, 5, 24, 48 and 72 h) 280 
mixed model analysis of variance (ANOVA).  Functional performance measures were analysed using 281 
the same model however with four fewer levels (Pre-supplement, Pre-trial, 24, 48 and 72 h).  Where 282 
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significant group baseline differences were apparent, results were normalised to baseline values.  As 283 
a result, post-exercise MVIC, hsCRP and cycling efficiency results were represented as a percentage 284 
of their baseline value, prior to subsequent statistical analysis.  MauĐhleǇ͛s Test of SpheriĐitǇ ǁas 285 
used to assess homogeneity of data and where violations were present, corrections were made 286 
using Greenhouse-Geiser adjustment.  Where necessary, interaction effects were assessed using LSD 287 
post-hoc analysis.  Prior to all analyses, a significance level of P < 0.05 was set. 288 
 289 
Results 290 
Baseline measures of MVIC were 634 ± 115 Newtons for MC and 713 ± 131 Newtons in the PLA 291 
group.  A group effect demonstrated that MVIC decline was significantly attenuated in the MC group 292 
(F(1,2) = 7,913, P = 0.014) versus PLA (Figure 3) with between group differences equating to 10, 12 and 293 
21% at 24, 48 and 72 h respectively, although there was no interaction effect present.  MVIC values 294 
in the MC group did not drop below baseline scores, whilst the PLA group scores remained 295 
depressed throughout the 72 h measurement period. 296 
 297 
No group effect was found for cycling efficiency following baselines measures of 41.1 ± 7.9  298 
mL.kg.min-1 for the MC group and 38.3 ± 10.6 mL.kg.min-1 in the PLA group. However, a significant 299 
interaction effect (F(1,4) = 4.336, P = 0.009) was observed.  Post-hoc testing identified a significant 300 
difference at 24 h (P = 0.015) where �̇O2 was 4% lower in the MC than the PLA group when 301 
normalised to baseline values.  DOMS demonstrated a significant main effect for time (F(1,4) = 4.902, 302 
P = 0.005) with increases in DOMS ratings reported in both groups; there were no group or 303 
interaction effects.  Baseline 6-second sprint power results were 785 ± 205 W and 834 ± 205 W for 304 
MC and PLA respectively.  Analysis demonstrated a significant effect for time (F(1,4) = 5.921, P = 305 
0.002), with power returning towards baseline values in both groups across the 72 hour post-trial 306 
period, but there were no group or interaction effects.  A summary of these measures are presented 307 
in Table 1. 308 
13 
 
 309 
Evaluation of plasma revealed baseline IL-6 values of 0.83 ± 0.43 and 1.15 ± 0.45 pg.mL-1 for MC and 310 
PLA groups respectively.  Data analysis showed a group effect (F(1,2) = 39.992, P < 0.001) 311 
demonstrating that the IL-6 response was significantly attenuated in the MC (vs. PLA) group across 312 
the protocol.  The peak group difference of 1.36 pg.mL-1, occurred immediately post-trial (Figure 4).  313 
Following measures taken at baseline (MC 1.14 ± 1.18 and PLA 0.55 ± 0.53 pg.mL-1), hsCRP remained 314 
lower in the MC group versus PLA group at all time points except 24 h (Figure 5).  Conversely in the 315 
PLA group, hsCRP values remained above baseline across the course of the study period.  Analysis of 316 
hsCRP data demonstrated significant differences between groups (F(1,2) = 2.431, P < 0.05)   The peak 317 
difference between groups (76%) occurred at 24 h post trial before a trend for both groups to return 318 
towards pre-exercise levels by 72 h.  Further markers of inflammation; IL-8 (F(1,9) = 25.364, P < 0.001) 319 
and TNF-α ;F(1,9) = 4.665, P < 0.001), muscle damage, CK (F(1,9) = 2.049, P < 0.05), and oxidative stress, 320 
LOOH (F(1,9) = 4.969, P < 0.001), all demonstrated main effects for time. Specifically, IL-8 was 321 
increased at post-trial and 1, 24 and 48 h (P < 0.05), CK was increased at post-trial, 3 and 5 h (P < 322 
0.05) and LOOH was significantly raised from pre-trial at 3 h (P < 0.05).  No group or interaction 323 
effects were found for any of these measures.  Lastly, IL-1-β did Ŷot show any group, time or 324 
interaction effects in response to the trial (Table 1).    325 
 326 
The total work done (kJ) across the exercise protocol was 155.1 ± 23.6 kJ and 151.3 ± 27.9 kJ for MC 327 
and PLA groups, respectively, which were not different between groups. Finally, food consumption 328 
data was not subjected to detailed scrutiny with regards to macro and micronutrient intake; 329 
however food diaries were reviewed for compliance with dietary restrictions.  Analysis of diaries 330 
revealed 100% adherence to the imposed dietary restrictions. 331 
 332 
Discussion 333 
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It was hypothesised that consumption of Montmorency cherry concentrate would both decrease the 334 
inflammatory and oxidative stress responses following a simulated cycling road race and accelerate 335 
recovery of functional performance.  In support of the hypothesis, there was no post-trial decline in 336 
MVIC performance with MC consumption indicating a protective effect on muscle function.  No 337 
other functional performance measures were different between groups over time.  With regards to 338 
inflammation, both IL-6 and hsCRP were attenuated in the MC group.  Conversely, IL-1-β, IL-8 and 339 
TNF-α did not differ between groups.  Contrary to our hypothesis, the oxidative stress response 340 
(LOOH) did not differ between groups.  Lastly, there were no differences in CK between groups at 341 
any point following the exercise task. 342 
 343 
With regards to MVIC, significant declines in performance were not apparent for the 72 h post-344 
exercise assessment period with MC supplementation.  On the contrary, PLA group performance of 345 
MVIC remained depressed below baseline at 72 h, with a 14% mean difference between groups.  346 
This finding suggests that MC consumption may preserve muscle function which normally declines in 347 
association with the post-exercise stress response.  Initial cellular disruption from the exercise stress 348 
is followed by a secondary inflammatory response which can further exacerbate the perturbations in 349 
homeostasis (Howatson and van Someren 2008).  Although there were no differences in the CK 350 
response between groups, there was reduced IL-6 and hsCRP found in the MC group, suggesting that 351 
the acute inflammatory stress response was dampened.  This may have resulted in a reduction in 352 
proteolytic and lipolytic cascades that are associated with inflammation via the cyclooxygenase, 353 
prostaglandin, IL-6 pathway (Trappe et al. 2013).  Whilst this is not the first study to demonstrate 354 
attenuated decline in MVIC performance with MC supplementation (Connolly et al. 2006; Howatson 355 
et al. 2010; Bowtell et al. 2011), it is the first to do so following exercise that did not include a 356 
mechanically damaging component through eccentric muscle actions and as a result, the stress 357 
responses caused can be attributed to metabolic and not a mechanical challenge.  The small 358 
increases in CK and DOMS observed in the current study also suggest that there was minimal muscle 359 
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cell membrane permeability which is associated with mechanical damage, and that the inflammatory 360 
responses can be attributed to metabolic processes.   As a result the preservation of MVIC in the MC 361 
group may be attributed to attenuated inflammation, and consequently may play a key role in 362 
recovery, independent of cellular disruption. 363 
 364 
The continued decline of MVIC performance after 48 h in the PLA group is a further interesting 365 
finding. Recovery of MVIC has been shown to return towards baseline 24-72 hours post-exercise 366 
previously (Connolly et al. 2006; Howatson et al. 2010).  However, the time-course of muscle 367 
function decline in the current study is not unique; previous literature has also demonstrated 368 
continued decline in muscle function (peak isokinetic torque) across 72 hours following eccentrically 369 
induced muscle damage (Cockburn et al. 2010).  Such contrasting responses may be attributed to 370 
differences in exercise mode, participant cohort and methods used to assess muscle function.  371 
Importantly however in regards to the current study, the maintenance of MVIC across the 72 h post-372 
exercise, indicates a protective effect of MC upon an aspect of muscle function. 373 
 374 
Although no interaction effects were found, a significant group difference showed hsCRP was 375 
elevated in the PLA group throughout the study.  To illustrate this, mean responses between 376 
baseline and pre-trial (loading phase) suggest MC provided a modest anti-inflammatory action prior 377 
to exercise.  Conversely, the removal of foods containing antioxidants in the PLA group diet 378 
appeared to cause a modest rise in inflammatory status (Figure 5) and as a result it may be surmised 379 
that habitual diets have an impact on daily inflammatory state.  Despite this, mean absolute hsCRP 380 
and IL-6 values were almost identical between groups immediately pre-trial, suggesting similar 381 
inflammatory states prior to exercise.  Regardless, the hsCRP response to exercise was consistent 382 
with previous work (Weight et al. 1991; Howatson et al. 2010); both groups peaked at 24 h before 383 
returning towards pre-exercise levels at 48 h.  Notably, the MC group demonstrated an attenuated 384 
rise versus PLA at 24 h (16% vs 96% increase from baseline).  With regards to IL-6, cycling has 385 
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previously been shown to increase plasma levels in the acute phase following performance (Robson-386 
Ansley et al. 2009) and furthermore, prolonged exercise involving significant muscle mass has been 387 
suggested to produce a marked increase in systemic levels regardless of the mode of exercise 388 
(Fischer 2006).  The suppressed IL-6 response with MC supplementation in the immediate hours 389 
following exercise in the present study is in agreement with previous work (Howatson et al. 2010) 390 
and thus provides further support to the anti-inflammatory properties of MC.  Additionally, no 391 
differences between groups were found with regards to work done, suggesting that the metabolic 392 
cost of the task was the same and that subsequent inflammatory processes had been induced by a 393 
similar stimulus in both groups.  With regards to application of these findings, reductions in 394 
inflammation may be beneficial to physical performance.  Indeed, administration of recombinant IL-395 
6 reduced 10 km running time-trial performance in trained male runners (Robson-Ansley et al. 396 
2004).  397 
 398 
In contrast to previous work (Connolly et al. 2006; Howatson et al. 2010), this investigation ensured 399 
the PLA supplement contained equal CHO content.  This is an important control measure as acute 400 
CHO ingestion has previously been reported to influence the appearance of IL-6 in plasma following 401 
strenuous exercise (Febbraio et al. 2003; Robson-Ansley et al. 2011).    Resultantly, the attenuation 402 
in inflammatory responses cannot be associated with pre-exercise carbohydrate (CHO) intake, 403 
although it should be noted that in applied scenarios, cyclists would be encouraged to ingest CHO 404 
throughout the exercise, possibly reducing the inflammatory response and limiting the 405 
generalizability of these results.  A more likely explanation for the anti-inflammatory actions of MC, 406 
however, may be that it inhibited the actions of prostaglandin enzymes responsible for the 407 
conversion of arachadonic acid to prostaglandins which play an important role in inflammatory 408 
pathways (Trappe and Liu 2013).  Future work might consider examination of these molecules to 409 
gain further understanding of the inflammatory cascade.  Wang et al. (1999) demonstrated in vitro, 410 
that cyanidin, the prominent anthocyanin within MC, was similarly effective in reducing the activity 411 
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of prostaglandin endoperoxide H synthase-1 and -2 to the non-steroidal anti-inflammatory drugs 412 
ibuprofen and naproxen.  Additionally, previous work has reported anthocyanin metabolites to be 413 
present in the circulation up to 48 h post-consumption (Czank et al. 2013) and as such may provide a 414 
potential mechanism for the results observed here. 415 
 416 
In contrast to our hypothesis, the oxidative stress (LOOH) responses to the trial were not different 417 
between groups despite showing elevations post-exercise versus pre-exercise measures.  Previous 418 
literature has demonstrated MC supplementation attenuated measures of lipid peroxidation 419 
(thiobarbituric acid reactive species [TBARS]) and a trend for reduced protein oxidation (protein 420 
carbonyls [PC]) in response to marathon running (Howatson et al. 2010) and maximal eccentric 421 
contractions of the knee extensors (Bowtell et al. 2011), respectively.  However, the use of both 422 
TBARS and PC as measures of oxidative stress in human studies have been criticised due to their lack 423 
of specificity (Urso and Clarkson 2003; Bell et al. 2013).  The TBARS assay has been suggested to also 424 
react with non-functional aldehydes, carbohydrates and prostaglandins (Alessio 2000), whereas 425 
carbonyl groups can also be formed from aldehyde groups formed during lipid peroxidation (Dalle-426 
Donne et al. 2003) thereby creating difficulty in discriminating between lipid and protein oxidation 427 
with the PC assay. Arguably, however this could be viewed as a strength when measuring global 428 
oxidative stress. The current study results suggest that the MC dose provided was not effective in 429 
reducing lipid peroxidation following the single bout of exercise performed, although conceivably 430 
the sample time points might miss peaks and modulation of these variables.  431 
 432 
The improved cycling efficiency at 24 h is an interesting observation; the MC group provided VO2 433 
values that were ~4% lower than those presented by the PLA group when results were normalised to 434 
baseline values.  This is not the first report of a functional food improving exercise efficiency; 435 
beetroot juice has previously been reported to lower the oxygen cost of submaximal exercise, which 436 
has been attributed to increased dietary nitrate impacting upon ATP expenditure in the maintenance 437 
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of sarcoplasmic Ca2+ homeostasis  (Bailey et al. 2009b; Vanhatalo et al. 2010).  Additionally, nitrate 438 
supplementation has been shown to reduce blood pressure in normotensive humans (Larsen et al. 439 
2006) suggesting an impact upon vascular function.  In relation to the current study, MC contains a 440 
high volume of polyphenols which have also been suggested to influence vascular function (Yung et 441 
al. 2008).  Although somewhat speculative, it is conceivable that the polyphenolic content of MC 442 
may have influenced endothelial function allowing improved blood flow and thereby contribute to 443 
improved exercise efficiency, but this needs to be confirmed and examined in a paradigm specifically 444 
designed to address this question.   445 
 446 
In contrast to the maintenance of MVIC with MC supplementation, it was surprising to notice no 447 
differences between groups in 6-second maximal power, which was measured to assess a cycle-448 
specific task.  In fact, surprisingly a main effect for time demonstrated that both groups actually 449 
improved this performance across the 72 h post-trial period.  In comparison with MVIC, the muscular 450 
movement and skill associated with cycle sprinting is far more complex.  As a result, it is possible 451 
that a learning effect may have influenced the improvement in performance, particularly given that 452 
the participants were endurance trained and were likely to be much less experienced to this type of 453 
maximal power test.  Future studies using such a measure in this population should consider a 454 
substantial familiarisation period prior to assessing 6-second maximal power.    455 
 456 
Interventions aimed at reducing the inflammatory and oxidative stress responses to exercise have 457 
received criticism with regards to their influence upon subsequent physiological adaptation; the 458 
suggestion is that attenuating inflammation and oxidative stress, could reduce protein synthesis 459 
(Trappe et al. 2002; Mikkelsen et al. 2009; Urso 2013) and dampen cell signalling (Gomez-Cabrera et 460 
al. 2012) and thereby inhibit adaptation (Paulsen et al. 2014).  Conversely, anti-inflammatory 461 
interventions have been suggested to have no effect on protein gene expression (Mikkelsen et al. 462 
2011) or repeated bout effect adaptation (Paulsen et al. 2010) and have recently been suggested to 463 
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be beneficial in increasing muscle hypertrophy in older adults (Trappe et al. 2011).  Additionally, no 464 
blunting effects on adaptation have been demonstrated with any functional food supplementation, 465 
although there is certainly a growing need for research in this area.  Regardless, many scenarios exist 466 
where accelerated recovery of performance is more important than physiological adaptation such as 467 
cycling tours and tournament based competitions; as a result, MC offers an efficacious strategy for 468 
physical recovery following strenuous exercise.   469 
 470 
Although functional performance decline following the trial was attenuated, a greater battery of 471 
sport specific performance measures, such as a time-trial, would have proved a useful inclusion.  In 472 
addition, the dosing strategy used in the study incorporated both pre-, on the day of, and post-trial 473 
supplementation; as a result it is difficult to ascertain the time at which MC exerts its positive 474 
effects, or whether there is a cumulative effect, whereby multiple doses result in an increased 475 
capacity to combat anti-inflammatory pathways or perhaps increase tissue bioavailability of the 476 
functional compounds.  Furthermore, the adherence to a low polyphenolic diet throughout the 477 
course of this study, limits the generalizability of the results.  Clearly, athletes would be encouraged 478 
to maintain a diet high in vegetables containing essential vitamins and minerals and the removal of 479 
these from the diet may have influenced the results of this study.  Future work might incorporate 480 
habitual diets to investigate if MC has an additive influence on the measures identified in this study.  481 
With regards to real-life appliĐatioŶ of this studǇ͛s results, it is iŵportaŶt to Ŷote that ŵost 482 
competitive cyclists will train or compete daily.  As a result, multiple days of exercise may have 483 
provided a more applied scenario where the increased stress responses are more representative of 484 
ĐǇĐlists͛ phǇsiĐal deŵaŶds.   485 
 486 
In summary, and in support of the hypothesis, the main finding of the study is that Montmorency 487 
cherry concentrate supplementation maintained muscle function (as determined by MVIC), 488 
following an exercise stress induced exclusively through a metabolic challenge.  This was 489 
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accompanied by the attenuation of inflammatory responses providing a possible mechanistic link to 490 
the performance benefits demonstrated.  This study provides new information which adds to the 491 
growing body of literature providing evidence for the use of MC supplementation in recovery from 492 
both metabolically and mechanically challenging exercise.  Given the findings in the current study 493 
and previous literature, future work should explore other sport specific applications for MC 494 
supplementation, such as field and court invasion sports, where the physiological stress is 495 
simultaneously challenging from a metabolic and mechanical perspective, which have both been 496 
shown in isolation to benefit from MC supplementation. 497 
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Figure Captions 
Figure 1.  Schematic of testing protocol.  All visits (excl. Visit 1) were conducted at 8am following an 
overnight fast.            
Blood sampling (      + performance measures).  
Supplementation period – 2 x 30 mL per day (8am and 6pm) taken with 100 mL water.  
Dietary restrictions – Following blood sampling at 96 h pre-trial to post-visit 6.  
 
Figure 2: Simulated road cycling race protocol (Vaile et al, 2008). Work - Maximal effort sprint. 
Recovery and ACT - Power at 40-50% Wmax. TT (Time Trial) - Sustained maximal effort. 
 
Figure 3: Maximum Voluntary Isometric Contraction responses (% Change from baseline) to 
Montmorency cherry concentrate (MC) and isoenergetic placebo (PLA). *Significant group effect (P < 
0.05), values are mean ± SD. 
 
Figure 4: Interleukin-6 responses to Montmorency cherry concentrate (MC) and isoenergetic 
placebo (PLA). *Significant group effect (P < 0.05), values are mean ± SD. 
 
Figure  5: high-sensitivity C-Reactive Protein responses (% of baseline) to Montmorency cherry 
concentrate (MC) and isoenergetic placebo (PLA). *Significant group effect (P < 0.05), values are 
mean ± SD.  
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10 minute warm up (Self-selected pace) 
Set Number 
Sprint 
Frequency/Duration 
Work to Recovery 
Ratio 
Set 1 12 x 5 s 1:6 (Work:Recovery) 
Set 2 12 x 5 s 1:3 (Work:Recovery) 
Set 3 12 x 5 s 1:1 (Work:Recovery) 
4 min ACT - 2 min TT - 4 min ACT 
Set 4 6 x 10 s 1:6 (Work:Recovery) 
Set 5 6 x 10 s 1:3 (Work:Recovery) 
Set 6 6 x 10 s 1:1 (Work:Recovery) 
4 min ACT - 2 min TT - 4 min ACT 
Set 7 4 x 15 s 1:6 (Work:Recovery) 
Set 8 4 x 15 s 1:3 (Work:Recovery) 
Set 9 4 x 15 s 1:1 (Work:Recovery) 
5 min ACT - 5 min TT - 5 min ACT 
 
Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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